Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches

被引:128
|
作者
Saman, Harman [1 ,2 ]
Raza, Syed Shadab [3 ]
Uddin, Shahab [4 ]
Rasul, Kakil [5 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, London E1 4NS, England
[2] Hazm Maubrairek Hosp, Dept Med, POB 305, Ar Rayyan, Qatar
[3] ERA Univ, Dept Stem Cell Biol & Regenerat Med, Lucknow 226003, Uttar Pradesh, India
[4] Hamad Med Corp, Acad Hlth Syst, Translat Res Inst, Doha 3050, Qatar
[5] Hamad Med Corp, Natl Canc Care & Res, Doha 3050, Qatar
关键词
angiogenesis; cancer; VEGF; anticancer; ENDOTHELIAL GROWTH-FACTOR; RECOMBINANT HUMAN ENDOSTATIN; VESSEL CO-OPTION; METASTATIC COLORECTAL-CANCER; ANTI-VEGF TREATMENT; TUMOR PROGRESSION; MEDIATES RESISTANCE; IN-VIVO; HEPATOCELLULAR-CARCINOMA; ANTIANGIOGENIC THERAPY;
D O I
10.3390/cancers12051172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is a term that describes the formation of new blood and lymphatic vessels from a pre-existing vasculature. This allows tumour cells to acquire sustenance in the form of nutrients and oxygen and the ability to evacuate metabolic waste. As one of the hallmarks of cancer, angiogenesis has been studied extensively in animal and human models to enable better understanding of cancer biology and the development of new anti-cancer treatments. Angiogenesis plays a crucial role in the process of tumour genesis, because solid tumour need a blood supply if they are to grow beyond a few millimeters in size. On the other hand, there is growing evidence that some solid tumour exploit existing normal blood supply and do not require a new vessel formation to grow and to undergo metastasis. This review of the literature will present the current understanding of this intricate process and the latest advances in the use of angiogenesis-targeting therapies in the fight against cancer.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Targeting angiogenesis for the treatment of prostate cancer
    Antonarakis, Emmanuel S.
    Carducci, Michael A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) : 365 - 376
  • [42] Angiogenesis inhibitors in the treatment of prostate cancer
    Clara Hwang
    Elisabeth I Heath
    Journal of Hematology & Oncology, 3
  • [43] Targeting angiogenesis with antibodies for the treatment of cancer
    Andreasson, P
    Carlsson, R
    IDRUGS, 2005, 8 (09) : 730 - 733
  • [44] Angiogenesis inhibitors in the treatment of lung cancer
    Shepherd, FA
    LUNG CANCER, 2001, 34 : S81 - S89
  • [45] Angiogenesis inhibitors in the treatment of colorectal cancer
    Iqbal, S
    Lenz, HJ
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 10 - 16
  • [46] Targeting Angiogenesis in the Treatment of Lung Cancer
    Wheatley-Price, Paul
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) : 1173 - 1184
  • [47] Angiogenesis as a new target for cancer treatment
    Ono, M
    Izumi, H
    Yoshida, S
    Goto, D
    Jimi, S
    Kawahara, N
    Shono, T
    Ushiro, S
    Ryuto, M
    Kohno, K
    Sato, Y
    Kuwano, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 : S78 - S82
  • [48] Angiogenesis Inhibition in the Treatment of Prostate Cancer
    Madan, Ravi A.
    Dahut, William L.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (10) : 1070 - 1078
  • [49] Angiogenesis inhibitors in the treatment of lung cancer
    Sun, Sophie
    Schiller, Joan H.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (02) : 93 - 104
  • [50] Angiogenesis and antiangiogenic treatment in lung cancer
    J. F. Morère
    J. M. Brechot
    R. Etessami
    Targeted Oncology, 2006, 1 : 215 - 219